SCHEMBL29008487

SCHEMBL29008487

CCCc1c[nH]c(-c2c[nH]nc2Cc2ccc(C(C)C)cc2)n1

nearest known ligand 0.33

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PNP P00491 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
COPS5 Q92905 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
UCHL3 P15374 1/20 0.30
CTSS P25774 1/20 0.30
CTSK P43235 1/20 0.30
IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29008496 0.85 HPGD (0.33)
SCHEMBL29008449 0.84 CDK5 (0.31)
SCHEMBL29008495 0.80 MAPT (0.36)
SCHEMBL29008461 0.80
SCHEMBL29008452 0.79
SCHEMBL29008474 0.79 HCAR2 (0.37)
SCHEMBL29008458 0.79 CTSS (0.30) CTSSCTSK
SCHEMBL29008472 0.79
SCHEMBL29008463 0.78
SCHEMBL29008482 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116194537-A Combination therapy with adenosine receptor antagonists 泰昂治疗公司 2023-05-30 CN disclosed